Matches in Wikidata for { <http://www.wikidata.org/entity/Q91984210> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q91984210 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91984210 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91984210 description "scientific article published on 16 April 2020" @default.
- Q91984210 description "wetenschappelijk artikel" @default.
- Q91984210 description "наукова стаття, опублікована 16 квітня 2020" @default.
- Q91984210 name "Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer" @default.
- Q91984210 name "Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer" @default.
- Q91984210 type Item @default.
- Q91984210 label "Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer" @default.
- Q91984210 label "Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer" @default.
- Q91984210 prefLabel "Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer" @default.
- Q91984210 prefLabel "Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer" @default.
- Q91984210 P1433 Q91984210-D56D825E-497B-46E7-B1E5-272C2050E6EF @default.
- Q91984210 P1476 Q91984210-9412BD51-7024-4195-A272-AF1ECA99B115 @default.
- Q91984210 P2093 Q91984210-1BE2F7A1-E3CF-4C50-9FA9-00BC5AEBB499 @default.
- Q91984210 P2093 Q91984210-1F1F406B-591D-41E2-A890-00D4FD04EB1D @default.
- Q91984210 P2093 Q91984210-29D451A5-EFA0-425B-8FDC-98F450E421A5 @default.
- Q91984210 P2093 Q91984210-2DE5D60F-73C1-47AB-97DE-14F5AFDADAFA @default.
- Q91984210 P2093 Q91984210-2E705765-7C52-4B42-9DE0-42B20F56DE6E @default.
- Q91984210 P2093 Q91984210-45519059-059B-47BD-8CE7-2AD2FB0D677B @default.
- Q91984210 P2093 Q91984210-86033EF5-95DE-4393-B4C8-FC7F8FA4EDE3 @default.
- Q91984210 P2093 Q91984210-B223A113-0721-4228-AFDA-364A7B3F08B9 @default.
- Q91984210 P2093 Q91984210-B528A526-C479-4D2B-8AFC-EBD9011918C4 @default.
- Q91984210 P2093 Q91984210-C79801B0-973E-4AE7-AB69-E9D80120A04F @default.
- Q91984210 P2093 Q91984210-D14FE8C1-5EAA-4A61-94E1-549F4BD367A4 @default.
- Q91984210 P2093 Q91984210-D2D2381D-7A9E-4FFD-92A1-1EFDDB1DFCC3 @default.
- Q91984210 P2093 Q91984210-FFA9C1CA-E450-4CBD-83DD-98BE87FF0285 @default.
- Q91984210 P2093 Q91984210-FFADB2C6-2E2F-4BD5-A09A-0961A2C05061 @default.
- Q91984210 P31 Q91984210-A74FFC72-78FB-4CEE-86D5-856EC1CCC027 @default.
- Q91984210 P356 Q91984210-213DF7B1-6CEF-4644-9B2F-8CD09EBEF9BD @default.
- Q91984210 P577 Q91984210-5F11C839-48D2-4194-973D-3EB69908D3EB @default.
- Q91984210 P698 Q91984210-3614A053-3EE9-41AB-AF36-3C3ACAE2D4E3 @default.
- Q91984210 P932 Q91984210-E249521D-4692-4D3C-B27D-1695F1FD960B @default.
- Q91984210 P356 JAMAONCOL.2020.0726 @default.
- Q91984210 P698 32297899 @default.
- Q91984210 P1433 Q22079683 @default.
- Q91984210 P1476 "Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer" @default.
- Q91984210 P2093 "Angélique Da-Silva" @default.
- Q91984210 P2093 "Anne-Flore Plane" @default.
- Q91984210 P2093 "Ariel A Cohen" @default.
- Q91984210 P2093 "Basile Chrétien" @default.
- Q91984210 P2093 "Charles Dolladille" @default.
- Q91984210 P2093 "Damien Legallois" @default.
- Q91984210 P2093 "Franck Thuny" @default.
- Q91984210 P2093 "Jennifer Cautela" @default.
- Q91984210 P2093 "Joachim Alexandre" @default.
- Q91984210 P2093 "Marion Sassier" @default.
- Q91984210 P2093 "Paul U Milliez" @default.
- Q91984210 P2093 "Sophie Fedrizzi" @default.
- Q91984210 P2093 "Stéphane Ederhy" @default.
- Q91984210 P2093 "Véronique Lelong-Boulouard" @default.
- Q91984210 P31 Q13442814 @default.
- Q91984210 P356 "10.1001/JAMAONCOL.2020.0726" @default.
- Q91984210 P577 "2020-04-16T00:00:00Z" @default.
- Q91984210 P698 "32297899" @default.
- Q91984210 P932 "7163782" @default.